{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.169","meta":{"versionId":"9","lastUpdated":"2021-03-06T01:01:01.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169","version":"20210306","name":"Irinotecan Injectable","status":"active","date":"2021-03-06T01:01:01-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1719772","display":"10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection"},{"code":"1726319","display":"2 ML irinotecan hydrochloride 20 MG/ML Injection"},{"code":"1726324","display":"5 ML irinotecan hydrochloride 20 MG/ML Injection"},{"code":"1726333","display":"15 ML irinotecan hydrochloride 20 MG/ML Injection"},{"code":"1726492","display":"25 ML irinotecan hydrochloride 20 MG/ML Injection"}]}]}}